Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 28-May-24 9:41 PM View:  | Emergent BioSolutions, Inc. (EBS) | 23-May-24 | Grant | 17,430 | -- | -- | 41% 42.44K to 59.87K | |
| 09-Feb-24 4:04 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 07-Feb-24 | Grant | 17,000 | -- | -- | 35% 48.0K to 65.0K | |
| 30-May-23 7:05 PM View: | Emergent BioSolutions, Inc. (EBS) | 25-May-23 | Grant | 33,847 | -- | -- | 394% 8.6K to 42.44K | |
| 03-Feb-23 4:52 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 02-Feb-23 | Grant | 16,000 | -- | -- | 50% 32.0K to 48.0K | |
| 07-Oct-22 4:05 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 06-Oct-22 | Option Exercise | 29,899 | $8.20 | $245,177.00 | 93% 32.0K to 61.9K | |
| 07-Oct-22 4:05 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 06-Oct-22 | Planned Option Sale | 29,899 | $25.90 | $774,411.00 | (48%) 61.9K to 32.0K | |
| 04-Oct-22 5:49 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 04-Oct-22 | Option Exercise | 360 | $8.53 | $3,070.95 | 1% 32.0K to 32.36K | |
| 04-Oct-22 5:49 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 04-Oct-22 | Planned Option Sale | 360 | $25.00 | $9,000.00 | (1%) 32.36K to 32.0K | |
| 04-Oct-22 5:49 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 03-Oct-22 | Option Exercise | 180 | $7.96 | $1,432.05 | < 1% 32.0K to 32.18K | |
| 04-Oct-22 5:49 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 03-Oct-22 | Planned Option Sale | 180 | $25.00 | $4,500.00 | (< 1%) 32.18K to 32.0K | |
| 04-Oct-22 5:49 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 30-Sep-22 | Option Exercise | 3,561 | $8.07 | $28,740.00 | 11% 32.0K to 35.56K | |
| 04-Oct-22 5:49 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 30-Sep-22 | Planned Option Sale | 3,561 | $25.07 | $89,276.80 | (10%) 35.56K to 32.0K | |
| 05-Apr-22 4:22 PM View: | Emergent BioSolutions, Inc. (EBS) | 02-Apr-22 | Grant | 8,595 | -- | -- | 100% 0 to 8.6K | |
| 03-Feb-22 5:30 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 02-Feb-22 | Grant | 16,000 | -- | -- | 100% 16.0K to 32.0K | |
| 21-May-21 8:57 PM View: | Rigel Pharmaceuticals, Inc. (RIGL) | 19-May-21 | Grant | 25,000 | -- | -- | 100% 0 to 25.0K | |
| 05-Feb-21 4:18 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 03-Feb-21 | Grant | 16,000 | -- | -- | 100% 0 to 16.0K | |
| 21-Feb-20 6:42 PM View: | Urovant Sciences Ltd. (UROV) | 19-Feb-20 | Payment of Exercise | 104,788 | $13.08 | $1,370,630.00 | (28%) 379.68K to 274.89K | (24%) |
| 21-Feb-20 6:42 PM View: | Urovant Sciences Ltd. (UROV) | 19-Feb-20 | Disposition (other) | 75,212 | $13.08 | $983,773.00 | (27%) 274.89K to 199.68K | (24%) |
| 21-Feb-20 6:42 PM View: | Urovant Sciences Ltd. (UROV) | 19-Feb-20 | Option Exercise | 180,000 | $3.86 | $694,800.00 | 90% 199.68K to 379.68K | |
| 09-Jan-20 4:33 PM View: | Urovant Sciences Ltd. (UROV) | 07-Jan-20 | Grant | 199,680 | -- | -- | 100% 0 to 199.68K | |
| 11-Dec-19 5:01 PM View: | Urovant Sciences Ltd. (UROV) | 09-Dec-19 | Option Exercise | 120,000 | $3.86 | $463,200.00 | 100% 0 to 120.0K | |
| 11-Dec-19 5:01 PM View: | Urovant Sciences Ltd. (UROV) | 09-Dec-19 | Market Option Sale | 120,000 | $12.78 | $1,533,600.00 | (100%) 120.0K to 0 | (27%) |
| 18-Dec-14 8:52 AM View: | Avanir Pharmaceuticals (AVNR) | 17-Dec-14 | Market Sale (Planned) | 62,520 | $16.93 | $1,058,460.00 | (6%) 976.77K to 914.25K | < 1% |
| 18-Dec-14 8:52 AM View: | Avanir Pharmaceuticals (AVNR) | 15-Dec-14 | Option Exercise | 195,160 | $1.61 | $314,396.00 | 20% 996.77K to 1.19M | |
| 18-Dec-14 8:52 AM View: | Avanir Pharmaceuticals (AVNR) | 15-Dec-14 | Market Option Sale (Planned) | 195,160 | $16.95 | $3,307,960.00 | (16%) 1.19M to 996.77K | < 1% |
| 18-Dec-14 8:52 AM View: | Avanir Pharmaceuticals (AVNR) | 15-Dec-14 | Market Sale (Planned) | 20,000 | $16.95 | $339,000.00 | (2%) 996.77K to 976.77K | < 1% |
| 12-Nov-14 10:00 PM View: | Avanir Pharmaceuticals (AVNR) | 10-Nov-14 | Grant | 361,174 | -- | -- | 57% 635.6K to 996.77K | |
| 24-Oct-14 8:34 PM View: | Avanir Pharmaceuticals (AVNR) | 24-Oct-14 | Market Sale (Planned) | 27,567 | $11.76 | $324,188.00 | (4%) 760.41K to 732.85K | (< 1%) |
| 01-Aug-14 8:44 PM View: | Avanir Pharmaceuticals (AVNR) | 01-Aug-14 | Market Sale (Planned) | 9,670 | $5.26 | $50,864.20 | (1%) 770.08K to 760.41K | (117%) |
| 10-Jul-14 7:42 PM View: | Avanir Pharmaceuticals (AVNR) | 09-Jul-14 | Grant | 20,000 | -- | -- | 3% 750.08K to 770.08K | |
| 30-May-14 8:00 PM View: | Avanir Pharmaceuticals (AVNR) | 28-May-14 | Market Sale (Planned) | 442,212 | $5.01 | $2,215,480.00 | (37%) 1.19M to 750.08K | (127%) |
| 14-Feb-14 7:52 PM View: | Avanir Pharmaceuticals (AVNR) | 12-Feb-14 | Grant | 354,375 | -- | -- | 80% 445.71K to 800.08K | |
| 20-Dec-13 5:24 PM View: | Avanir Pharmaceuticals (AVNR) | 18-Dec-13 | Market Sale (Planned) | 29,515 | $2.67 | $78,934.90 | (6%) 475.22K to 445.71K | (326%) |
| 05-Nov-13 8:00 PM View: | Avanir Pharmaceuticals (AVNR) | 01-Nov-13 | Market Sale (Planned) | 4,385 | $4.14 | $18,137.70 | (< 1%) 479.61K to 475.22K | (175%) |
| 02-Aug-13 7:58 PM View: | Avanir Pharmaceuticals (AVNR) | 02-Aug-13 | Market Sale (Planned) | 15,500 | $4.84 | $74,981.20 | (3%) 495.11K to 479.61K | (135%) |
| 17-May-13 8:02 PM View: | Avanir Pharmaceuticals (AVNR) | 15-May-13 | Option Exercise | 215,438 | $0.79 | $170,055.00 | 41% 530.11K to 745.54K | |
| 17-May-13 8:02 PM View: | Avanir Pharmaceuticals (AVNR) | 15-May-13 | Market Option Sale (Planned) | 215,438 | $3.26 | $702,229.00 | (29%) 745.54K to 530.11K | (249%) |
| 17-May-13 8:02 PM View: | Avanir Pharmaceuticals (AVNR) | 15-May-13 | Market Sale (Planned) | 35,000 | $3.26 | $114,084.00 | (7%) 530.11K to 495.11K | (249%) |
| 05-Dec-12 4:39 PM View: | Avanir Pharmaceuticals (AVNR) | 03-Dec-12 | Market Sale (Planned) | 18,250 | $2.55 | $46,457.20 | (13%) 137.73K to 119.48K | (347%) |
| 27-Jun-12 5:00 PM View: | Avanir Pharmaceuticals (AVNR) | 25-Jun-12 | Market Sale | 190,125 | $3.50 | $664,791.00 | (58%) 327.86K to 137.73K | (384%) |
| 07-Mar-12 9:00 AM View: | Avanir Pharmaceuticals (AVNR) | 06-Mar-12 | Market Purchase | 10,000 | $2.61 | $26,093.00 | 3% 317.86K to 327.86K | 333% |
| 16-Dec-11 8:39 PM View: | Avanir Pharmaceuticals (AVNR) | 15-Dec-11 | Grant | 127,000 | -- | -- | 67% 190.86K to 317.86K | |
| 06-Dec-11 5:01 PM View: | Avanir Pharmaceuticals (AVNR) | 02-Dec-11 | Market Sale (Planned) | 17,495 | $2.37 | $41,421.20 | (8%) 208.35K to 190.86K | (379%) |
| 18-Nov-11 8:01 PM View: | Avanir Pharmaceuticals (AVNR) | 17-Nov-11 | Option Exercise | 109,012 | $0.87 | $95,025.10 | 52% 208.35K to 317.36K | |
| 18-Nov-11 8:01 PM View: | Avanir Pharmaceuticals (AVNR) | 17-Nov-11 | Market Option Sale (Planned) | 109,012 | $2.59 | $282,657.00 | (34%) 317.36K to 208.35K | (337%) |
| 18-Nov-11 8:01 PM View: | Avanir Pharmaceuticals (AVNR) | 16-Nov-11 | Option Exercise | 109,013 | $0.53 | $57,776.90 | 52% 208.35K to 317.37K | |
| 18-Nov-11 8:01 PM View: | Avanir Pharmaceuticals (AVNR) | 16-Nov-11 | Market Option Sale | 109,013 | $2.59 | $282,300.00 | (34%) 317.37K to 208.35K | (337%) |
| 03-Dec-10 8:55 PM View: | Avanir Pharmaceuticals (AVNR) | 02-Dec-10 | Option Exercise | 195,300 | $0.53 | $103,509.00 | 94% 208.35K to 403.65K | |
| 03-Dec-10 8:55 PM View: | Avanir Pharmaceuticals (AVNR) | 02-Dec-10 | Market Option Sale | 195,300 | $4.08 | $797,254.00 | (48%) 403.65K to 208.35K | (173%) |
| 03-Dec-10 8:55 PM View: | Avanir Pharmaceuticals (AVNR) | 01-Dec-10 | Grant | 62,500 | -- | -- | 43% 145.85K to 208.35K |